Granicip 1 DT Tablet
By Granicip
Rx
4 Tablet DT in a Strip

Composition
Granisetron(1mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
October, 2025

liver
Granicip 1 DT Tablet is considered safe for use in patients with liver disease based on the limited available data. It appears that there may not be a need to adjust the dosage of Granicip 1 DT Tablet in these patients. It is important to consult your doctor before taking this medication if you have any liver concerns.

kidney
Granicip 1 DT Tablet is generally considered safe for use in patients with kidney disease. It is likely that dose adjustment may not be necessary in these individuals. It is recommended to consult your doctor regarding the use of this medication.

alcohol
Consult your doctor when consuming alcohol with Granicip 1 DT Tablet.

driving
Granicip 1 DT Tablet generally does not impact driving ability.

pregnancy
Granicip 1 DT Tablet is generally considered safe to use during pregnancy. Animal studies suggest low or no adverse effects on the developing baby, but limited human studies are available.

breastfeeding
Granicip 1 DT Tablet is considered safe during breastfeeding as limited human data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | Indazole Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Serotonin antagonists (5-HT3 antagonists) |
₹122.45
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024